venture company

Aravis is the first independent Swiss on-shore private equity house, an established investor in the renewable energy and life science spaces.

Located in Zurich, Aravis is the first independent Swiss on-shore priv...
See More ate equity house. With a track record of investment in the renewable energy and life science spaces, the company has honed an investment expertise that transcends industry sectors.

Founded in 2001, Aravis’ funds have a track record of success in the service of over 30 leading investors including corporate, pension funds, government funds, insurance companies and family offices. Currently actively managing more than a quarter of a billion Swiss francs, Aravis has a cumulative history of investments in over 100 companies.

An established investor in renewable energy, the Aravis ENERGY team have demonstrated their ability to attract syndicate and structure complex projects resulting to date in the divestment of three renewable energy companies producing in excess of 100 Giga Watt hours.

With a long track record in life sciences and two life science investment funds (ARAVIS Biotech I and ARAVIS Biotech II), Aravis has held an early stage stake in some of the more eye-catching Swiss life science companies and has had over the years some notable exits through reverse takeover, IPO or acquisition.

Aravis has a distinct and crafted approach to investment, taking a “hands on” approach that balances between finance, commercial assets and people. This approach transcends industry sector and with years of collected experience and expertise, Aravis has established a comprehensive investment platform that also incorporates accounting, regulatory and reporting expertise specific to Switzerland but also more widely. This means that Aravis is well placed to manage external funds for clients and institutions as well as putting together further internal funds focused on current and new industry sectors.